Aehr Test Systems (NASDAQ:AEHR) Shares Gap Down – What’s Next?

Aehr Test Systems (NASDAQ:AEHR)’s stock price gapped down before the market opened on Monday . The stock had previously closed at $101.73, but opened at $95.76. Aehr Test Systems shares last traded at $93.5310, with a volume of 425,543 shares traded.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. Lake Street Capital reissued a “buy” rating and issued a $110.00 target price on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Zacks Research upgraded shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research note on Friday, July 17th. Wall Street Zen raised Aehr Test Systems from a “sell” rating to a “hold” rating in a report on Saturday, July 18th. Weiss Ratings downgraded Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a report on Wednesday, July 29th. Finally, Freedom Capital upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 16th. Two equities research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $136.67.

Aehr Test Systems Stock Down 5.6%

The company has a market capitalization of $3.13 billion, a P/E ratio of -399.92 and a beta of 3.10. The stock has a fifty day simple moving average of $94.63 and a 200-day simple moving average of $74.93.

Insider Buying and Selling at Aehr Test Systems

In related news, Director Howard T. Slayen sold 5,700 shares of Aehr Test Systems stock in a transaction dated Friday, August 14th. The shares were sold at an average price of $133.03, for a total transaction of $758,271.00. Following the completion of the transaction, the director directly owned 140,667 shares of the company’s stock, valued at $18,712,931.01. This trade represents a 3.89% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Laura Oliphant sold 1,717 shares of the business’s stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $133.00, for a total transaction of $228,361.00. Following the completion of the transaction, the director owned 16,100 shares in the company, valued at approximately $2,141,300. This trade represents a 9.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 109,475 shares of company stock worth $13,827,160 over the last ninety days. Company insiders own 6.80% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Royal Bank of Canada increased its holdings in Aehr Test Systems by 262.7% during the 1st quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock valued at $365,000 after purchasing an additional 36,364 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Aehr Test Systems by 8.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock worth $126,000 after purchasing an additional 1,344 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Aehr Test Systems by 7.9% in the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock valued at $201,000 after buying an additional 1,145 shares in the last quarter. Legal & General Group Plc increased its stake in shares of Aehr Test Systems by 110.8% in the second quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock valued at $89,000 after buying an additional 3,617 shares in the last quarter. Finally, Rhumbline Advisers raised its holdings in shares of Aehr Test Systems by 3.1% in the second quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock valued at $536,000 after buying an additional 1,254 shares during the last quarter. 69.69% of the stock is owned by institutional investors and hedge funds.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.